{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 458614308
| IUPAC_name = (1''S*'',2''R*'')-(±)-4-(1-Hydroxy-2-methylamino-propyl)phenol
| image = Oxilofrin Structural Formulae V.1.svg
| width = 250px

<!--Clinical data-->
| tradename =
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_category =
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status = Uncontrolled
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability =
| protein_bound =
| metabolism =
| elimination_half-life =
| excretion =

<!--Identifiers-->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 365-26-4
| ATC_prefix = none
| ATC_suffix =
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 30400
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C10H15NO2/c1-7(11-2)10(13)8-3-5-9(12)6-4-8/h3-7,10-13H,1-2H3
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = OXFGTKPPFSCSMA-UHFFFAOYSA-N
| PubChem = 9701
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 9320
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = F49638UBDR
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D08314

<!--Chemical data-->
| C=10 | H=15 | N=1 | O=2
| molecular_weight = 181.23 g/mol
}}

'''Oxilofrine''' (also known as '''methylsynephrine''', '''hydroxyephrine''', '''oxyephrine''', and '''4-HMP''') is a [[stimulant]] [[drug]]<ref> {{cite book | last1 = Fourcroy | first1 = Jean L. | title = Pharmacology, doping and sports: a scientific guide for athletes, coaches, physicians, scientists and administrators | publisher = Taylor & Francis | year = 2008 | isbn = 978-0-415-42845-3}}</ref> and is an [[amphetamine]] chemically related to [[ephedrine]] and to [[synephrine]].

Oxilofrine is currently a [[World_Anti-Doping_Agency|WADA]] prohibited substance when used in competition.<ref>http://list.wada-ama.org/prohibited-in-competition/prohibited-substances/</ref> It is an ingredient found in some dietary supplements.

== Publicized cases ==
*In 2009, Brazilian/American cyclist [[Flávia Oliveira]] was suspended for 2 years after taking a supplement known as "HyperDrive 3.0+" which contained methylsynephrine, a chemical equivalent of oxilofrine, among other substances. <ref>{{cite news|url=http://velonews.competitor.com/2010/04/news/oliveira-suspended-for-two-years_111571| title=Oliveira suspended for two years|date=2010-04-13|author=Charles Pelkey|publisher=Velonews}}</ref> Her sentence was eventually reduced to 18 months after an appeal as there was enough evidence that she had unknowingly consumed said substance as the old label did not list methylsynephrine.<ref>{{cite news|url=http://velonews.competitor.com/2010/12/news/court-of-arbitration-for-sport-reduces-flavia-olivera-suspension_152082| title=Court of Arbitration for Sport reduces Flavia Oliveira suspension|date=2011-02-24|author=Charles Pelkey|publisher=Velonews}}</ref>
* On July 14, 2013, Jamaican runners [[Asafa Powell]] and [[Sherone Simpson]] tested positive for oxilofrine prior to the [[2013 World Championships in Athletics|2013 World Athletics Championships]]. <ref>{{cite web|author=Reuters |url=http://www.supersport.com/athletics/international/news/13071/Five_Jamaicans_test_positive_for_banned_drugs |title=Jamaicans Powell, Simpson test positive - SuperSport - Athletics |publisher=SuperSport |date= |accessdate=2013-07-15}}</ref> Powell, however, maintained that he did not take any banned supplements knowingly or willfully.<ref name="bp">{{cite web|title=Jamaican Sprinter Asafa Powell slapped 18-month ban for doping|url=http://news.biharprabha.com/2014/04/jamaican-sprinter-asafa-powell-slapped-18-month-ban-for-doping/|work=IANS|publisher=news.biharprabha.com|accessdate=10 April 2014}}</ref> Powell voluntarily withdrew as a result of the test. On 10 April 2014, both athletes received an 18-month suspension from competing, which was set to expire in December that year.<ref name="Powell and Simpson suspended">{{Cite web|url = http://www.bbc.co.uk/sport/0/athletics/26974788|title = Asafa Powell banned for 18 months for doping|date = 10 April 2014|website = [[BBC Sport]]|archiveurl = https://web.archive.org/web/20140509060737/http://www.bbc.co.uk/sport/0/athletics/26974788|archivedate = 9 May 2014}}</ref> However, after appealing to the [[Court of Arbitration for Sport]] (CAS), both athletes' suspensions were lifted on 14 July 2014.<ref name="Powell and Simpson suspensions lifted">{{cite news |url=http://www.dailymail.co.uk/sport/othersports/article-2691938/Asafa-Powell-Sherone-Simpson-doping-bans-reduced-six-months.html |title=Asafa Powell and Sherone Simpson given green light to return to action after sprinters have doping bans reduced to six months |newspaper=[[Mail Online]] |last=Drayton |first=John |date=14 July 2014 |accessdate=14 July 2014}}</ref>
* On July 16, 2015, [[Chicago White Sox]] pitching prospect [[Michael Kopech]] was suspended without pay for 50 games after testing positive for oxilofrine, which is a banned substance under the Minor League Drug Prevention and Treatment Program. Kopech denied knowingly taking the substance.<ref>{{cite web|author=Danny Wild |url=http://www.milb.com/news/article.jsp?ymd=20150716&content_id=136960248&fext=.jsp&vkey=news_milb&sid=milb |title=Red Sox No. 10 prospect Kopech suspended |publisher=[[Minor League Baseball|MiLB.com]] |date=16 July 2015 |accessdate=8 March 2016}}</ref>

==References==
{{Reflist}}


{{Stimulants}}
{{Adrenergics}}
{{Phenethylamines}}

[[Category:Substituted amphetamines]]
[[Category:Norepinephrine releasing agents]]


{{nervous-system-drug-stub}}